Terms: = Germ cell tumor AND NPM1, NPM, 4869, ENSG00000181163, P06748, B23, MGC104254 AND Prognosis
11 results:
1. Clinicopathological characteristics of new primary melanomas in patients receiving immune checkpoint inhibitor therapy for metastatic melanoma.
Pennington TE; Zhao CY; Colebatch AJ; Fernandez-Peñas P; Guitera P; Burke H; Scolyer RA; Menzies AM; Carlino MS; Lo S; Long GV; Saw RP
Australas J Dermatol; 2022 May; 63(2):e133-e137. PubMed ID: 35188271
[TBL] [Abstract] [Full Text] [Related]
2. Inhibition of the de novo pyrimidine biosynthesis pathway limits ribosomal RNA transcription causing nucleolar stress in glioblastoma cells.
Lafita-Navarro MC; Venkateswaran N; Kilgore JA; Kanji S; Han J; Barnes S; Williams NS; Buszczak M; Burma S; Conacci-Sorrell M
PLoS Genet; 2020 Nov; 16(11):e1009117. PubMed ID: 33201894
[TBL] [Abstract] [Full Text] [Related]
3. Comprehensive Genomic Analysis of Noonan Syndrome and Acute Myeloid Leukemia in Adults: A Review and Future Directions.
Alhumaid MS; Dasouki MJ; Ahmed SO; AbalKhail H; Hagos S; Wakil S; Hashmi SK
Acta Haematol; 2020; 143(6):583-593. PubMed ID: 32541138
[TBL] [Abstract] [Full Text] [Related]
4. Clinical Utility of Next-Generation Sequencing in Acute Myeloid Leukemia.
Yang F; Anekpuritanang T; Press RD
Mol Diagn Ther; 2020 Feb; 24(1):1-13. PubMed ID: 31848884
[TBL] [Abstract] [Full Text] [Related]
5. [Features of the Structure and Expression of npm and NCL Genes in Cutaneous Melanoma].
Ponkratova DA; Lushnikova AA
Mol Biol (Mosk); 2019; 53(4):663-673. PubMed ID: 31397440
[TBL] [Abstract] [Full Text] [Related]
6. Upregulation of b23 promotes tumor cell proliferation and predicts poor prognosis in glioma.
Chen J; Sun J; Yang L; Yan Y; Shi W; Shi J; Huang Q; Chen J; Lan Q
Biochem Biophys Res Commun; 2015 Oct; 466(1):124-30. PubMed ID: 26343305
[TBL] [Abstract] [Full Text] [Related]
7. Quantitative proteomic analysis shows differentially expressed HSPB1 in glioblastoma as a discriminating short from long survival factor and NOVA1 as a differentiation factor between low-grade astrocytoma and oligodendroglioma.
Gimenez M; Marie SK; Oba-Shinjo S; Uno M; Izumi C; Oliveira JB; Rosa JC
BMC Cancer; 2015 Jun; 15():481. PubMed ID: 26108672
[TBL] [Abstract] [Full Text] [Related]
8. Quantitative proteomic analysis and functional studies reveal that nucleophosmin is involved in cell death in glioblastoma cell line transfected with siRNA.
Gimenez M; Marie SK; Oba-Shinjo SM; Uno M; da Silva R; Laure HJ; Izumi C; Otake A; Chammas R; Rosa JC
Proteomics; 2012 Aug; 12(17):2632-40. PubMed ID: 22745010
[TBL] [Abstract] [Full Text] [Related]
9. Identification of histological markers for malignant glioma by genome-wide expression analysis: dynein, alpha-PIX and sorcin.
Yokota T; Kouno J; Adachi K; Takahashi H; Teramoto A; Matsumoto K; Sugisaki Y; Onda M; Tsunoda T
Acta Neuropathol; 2006 Jan; 111(1):29-38. PubMed ID: 16320026
[TBL] [Abstract] [Full Text] [Related]
10. Clinical prognostic factors in 1277 patients with neuroblastoma: results of The European Neuroblastoma Study Group 'Survey' 1982-1992.
Cotterill SJ; Pearson AD; Pritchard J; Foot AB; Roald B; Kohler JA; Imeson J
Eur J Cancer; 2000 May; 36(7):901-8. PubMed ID: 10785596
[TBL] [Abstract] [Full Text] [Related]
11. Combinatorial effects of monoclonal anti-p120 antibody (MAbp120), liposomes and hyperthermia on MCF-7 and LOX tumor cell lines.
Perlaky L; Busch RK; Busch H
Oncol Res; 1996; 8(9):363-9. PubMed ID: 8979270
[TBL] [Abstract] [Full Text] [Related]
